Takeda, NY Academy of Sciences establish $200k research prize; CapsoVision receives FDA clearance for CapsoCam Plus & more: 5 GI company key notes

Here are five updates on gastroenterology and endoscopy companies.

Advertisement

Osaka, Japan-based Takeda Pharmaceutical and the New York Academy of Sciences established the Takeda Innovators in Science Award.

Saratoga, Calif.-based CapsoVision earned FDA 510(k) clearance for its small bowel capsule endoscope system, CapsoCam Plus.

As Rancho Santa Margarita, Calif-based Integrated Endoscopy prepares for the early 2017 launch of its single-use arthroscope, the company appointed several new members to its corporate leadership team.

New York-based Intercept Pharmaceuticals released data from three studies related to the Phase 3 POISE trial of Ocaliva.

New Haven, Conn.-based Alexion Pharmaceuticals has released data from studies related to the Phase 3 ARISE trial of Kanuma

More articles on gastroenterology and endoscopy:
50% of patients treated with Kanuma experience reduced liver fibrosis: 3 study insights
Takeda Pharmaceutical, New York Academy of Sciences establish $200k research prize: 3 notes
AGA, NACCME develop 3 regional educational programs about IBD: 3 notes

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.